214 related articles for article (PubMed ID: 8259654)
41. Viral genetic variation, AIDS, and the multistep nature of carcinogenesis: the feline leukemia virus model.
Rohn JL; Gwynn SR; Lauring AS; Linenberger ML; Overbaugh J
Leukemia; 1996 Dec; 10(12):1867-9. PubMed ID: 8946923
[TBL] [Abstract][Full Text] [Related]
42. Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein.
Brojatsch J; Kristal BS; Viglianti GA; Khiroya R; Hoover EA; Mullins JI
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8457-61. PubMed ID: 1326757
[TBL] [Abstract][Full Text] [Related]
43. Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats.
Pepin AC; Tandon R; Cattori V; Niederer E; Riond B; Willi B; Lutz H; Hofmann-Lehmann R
Virus Res; 2007 Jul; 127(1):9-16. PubMed ID: 17434224
[TBL] [Abstract][Full Text] [Related]
44. Fecal shedding of infectious feline leukemia virus and its nucleic acids: a transmission potential.
Gomes-Keller MA; Gönczi E; Grenacher B; Tandon R; Hofman-Lehmann R; Lutz H
Vet Microbiol; 2009 Mar; 134(3-4):208-17. PubMed ID: 18842363
[TBL] [Abstract][Full Text] [Related]
45. Long-term follow up of feline leukemia virus infection and characterization of viral RNA loads using molecular methods in tissues of cats with different infection outcomes.
Helfer-Hungerbuehler AK; Widmer S; Kessler Y; Riond B; Boretti FS; Grest P; Lutz H; Hofmann-Lehmann R
Virus Res; 2015 Feb; 197():137-50. PubMed ID: 25553598
[TBL] [Abstract][Full Text] [Related]
46. Quantitation of feline leukaemia virus viral and proviral loads by TaqMan real-time polymerase chain reaction.
Tandon R; Cattori V; Gomes-Keller MA; Meli ML; Golder MC; Lutz H; Hofmann-Lehmann R
J Virol Methods; 2005 Dec; 130(1-2):124-32. PubMed ID: 16054243
[TBL] [Abstract][Full Text] [Related]
47. Feline leukemia virus outbreak in the critically endangered Iberian lynx (Lynx pardinus): high-throughput sequencing of envelope variable region A and experimental transmission.
Geret CP; Cattori V; Meli ML; Riond B; Martínez F; López G; Vargas A; Simón MA; López-Bao JV; Hofmann-Lehmann R; Lutz H
Arch Virol; 2011 May; 156(5):839-54. PubMed ID: 21302124
[TBL] [Abstract][Full Text] [Related]
48. Cytopathic feline leukemia viruses cause apoptosis in hemolymphatic cells.
Rojko JL; Hartke JR; Cheney CM; Phipps AJ; Neil JC
Prog Mol Subcell Biol; 1996; 16():13-43. PubMed ID: 8822790
[TBL] [Abstract][Full Text] [Related]
49. Endogenous Feline Leukemia Virus (FeLV) siRNA Transcription May Interfere with Exogenous FeLV Infection.
Chiu ES; McDonald CA; VandeWoude S
J Virol; 2021 Nov; 95(23):e0007021. PubMed ID: 34495702
[TBL] [Abstract][Full Text] [Related]
50. Lymphocytotoxic strains of feline leukemia virus induce apoptosis in feline T4-thymic lymphoma cells.
Rojko JL; Fulton RM; Rezanka LJ; Williams LL; Copelan E; Cheney CM; Reichel GS; Neil JC; Mathes LE; Fisher TG
Lab Invest; 1992 Apr; 66(4):418-26. PubMed ID: 1349933
[TBL] [Abstract][Full Text] [Related]
51. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
Chandhasin C; Coan PN; Levy LS
J Virol; 2005 Feb; 79(3):1351-60. PubMed ID: 15650161
[TBL] [Abstract][Full Text] [Related]
52. The kinetics of feline leukaemia virus shedding in experimentally infected cats are associated with infection outcome.
Cattori V; Tandon R; Riond B; Pepin AC; Lutz H; Hofmann-Lehmann R
Vet Microbiol; 2009 Jan; 133(3):292-6. PubMed ID: 18774240
[TBL] [Abstract][Full Text] [Related]
53. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
[TBL] [Abstract][Full Text] [Related]
54. The location in cartilage of infectious retrovirus in cats infected with feline leukemia virus.
Arnoczky SP; Swenson C; Egerbacher M; Gardner K; Caballero O; Burns M
J Bone Joint Surg Am; 2007 Sep; 89(9):2030-6. PubMed ID: 17768202
[TBL] [Abstract][Full Text] [Related]
55. Identification and deletion of sequences required for feline leukemia virus RNA packaging and construction of a high-titer feline leukemia virus packaging cell line.
Burns CC; Moser M; Banks J; Alderete JP; Overbaugh J
Virology; 1996 Aug; 222(1):14-20. PubMed ID: 8806483
[TBL] [Abstract][Full Text] [Related]
56. The surface glycoprotein of feline leukemia virus isolate FeLV-945 is a determinant of altered pathogenesis in the presence or absence of the unique viral long terminal repeat.
Bolin LL; Ahmad S; Lobelle-Rich PA; Ooms TG; Alvarez-Hernandez X; Didier PJ; Levy LS
J Virol; 2013 Oct; 87(19):10874-83. PubMed ID: 23903838
[TBL] [Abstract][Full Text] [Related]
57. Prophylactic and therapeutic effects of phosphonoformate against feline leukemia virus in vitro.
Swenson CL; Polas PJ; Cheney CM; Kociba GJ; Mathes LE
Am J Vet Res; 1991 Dec; 52(12):2010-5. PubMed ID: 1724122
[TBL] [Abstract][Full Text] [Related]
58. Influence of adrenal corticosteroids on the susceptibility of cats to feline leukemia virus infection.
Rojko JL; Hoover EA; Mathes LE; Krakowka S; Olsen RG
Cancer Res; 1979 Sep; 39(9):3789-91. PubMed ID: 225025
[TBL] [Abstract][Full Text] [Related]
59. Multiple recombination events between endogenous retroviral elements and feline leukemia virus.
Ngo MH; AbuEed L; Kawasaki J; Oishi N; Pramono D; Kimura T; Sakurai M; Watanabe K; Mizukami Y; Ochi H; Anai Y; Odahara Y; Umehara D; Kawamura M; Watanabe S; Miyake A; Nishigaki K
J Virol; 2024 Feb; 98(2):e0140023. PubMed ID: 38240589
[TBL] [Abstract][Full Text] [Related]
60. Pathogenic and host range determinants of the feline aplastic anemia retrovirus.
Riedel N; Hoover EA; Dornsife RE; Mullins JI
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2758-62. PubMed ID: 2833751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
